Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Hyperplasia and BRCA2[original query] |
|---|
| High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 12 21 (1): 41-5. Hoogerbrugge N, Bult P, de Widt-Levert L M, Beex L V, Kiemeney L A, Ligtenberg M J L, Massuger L F, Boetes C, Manders P, Brunner H |
| ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers. Genes, chromosomes & cancer 2004 Sep 41 (1): 1-11. Adem Camilo, Soderberg Cheryl L, Hafner Kari, Reynolds Carol, Slezak Jeffrey M, Sinclair Colleen S, Sellers Thomas A, Schaid Daniel J, Couch Fergus, Hartmann Lynn C, Jenkins Robert |
| Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2008 Oct 34 (10): 1148-54. Isern A E, Loman N, Malina J, Olsson H, Ringberg |
| A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers. Gynecologic oncology 2014 Sep 134 (3): 492-7. Cass Ilana, Walts Ann E, Barbuto Denise, Lester Jenny, Karlan Be |
| Lower Urinary Tract Symptoms and Benign Prostate Hyperplasia Features Among Male BRCA Mutation Carriers. Urology 2017 Oct 108 71-75. Goldberg Hanan, Grievink Liat Shavit, Mano Roy, Ber Yaara, Ozalbo Rachely, Tuval Sivan, Baniel Jack, Margel Dav |
| Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy. Cirugia espanola 2020 Jun . Allué Cabañuz Marta, Domingo Bretón María, Chóliz Ezquerro Jorge, Arribas Del Amo María Dolores, Güemes Sánchez Antonio Tom |
| Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes. Journal of translational medicine 2023 7 21 (1): 446. Xiaohao Ruan, Da Huang, Jingyi Huang, James Hok-Leung Tsu, Rong |
| Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. The Prostate 2024 1 . Jason A White, Ernest T Kaninjing, Kayode A Adeniji, Paul Jibrin, John O Obafunwa, Chidiebere N Ogo, Faruk Mohammed, Ademola Popoola, Omolara A Fatiregun, Olabode P Oluwole, Roland J Thorpe, Balasubramanyam Karanam, Isra Elhussin, Stefan Ambs, Wei Tang, Melissa Davis, Paz Polak, Moray J Campbell, Kathryn R Brignole, Solomon O Rotimi, Windy Dean-Colomb, Folake T Odedina, Clayton Yat |
- Page last reviewed:Feb 1, 2024
- Content source: